Flow Neuroscience announced that the FDA approved its Flow at-home brain stimulation device for treating major depressive ...

Because of rising rates of anxiety, depression and other mental health concerns among adolescents, TMS has been used off-label for many years to treat depression among teenagers. The US Centers for ...

As previously announced, low dose D-cycloserine has been associated with augmentation of the antidepressant and antisuicidal ...

Sutter Health is the first hospital in the Sacramento Region to offer accelerated TMS therapy for treatment-resistant ...

WEST VIRGINIA (WVNS) – Millions of Americans living with major depressive disorder struggle to find treatment options that ...

(RTTNews) - Neuronetics, Inc. (STIM), a neurohealth technology company, on Wednesday announced the publication of two significant peer-reviewed studies in the inaugural issue of the Transcranial ...

NEW YORK ― Transcranial magnetic stimulation (TMS) is a cost-effective treatment option for patients with resistant major depressive disorder (MDD), according to a new economic analysis. "It's mainly ...

Austin, Texas, United States, December 3rd, 2025, FinanceWire NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, said ...

BURLINGTON, Mass. and JERUSALEM, Oct. 16, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (BWAY) (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation ...

Please provide your email address to receive an email when new articles are posted on . Transcranial magnetic stimulation targets the central executive network. 80% of patients responded by 20 ...

Unlike commonly used oral antidepressants (often known as selective serotonin reuptake inhibitors or SSRIs), ketamine works through a different mechanism. It targets glutamate pathways in the brain, ...